MergerLinks - Nick Bell

target

Formulated Solutions

bidder

Linden Capital Partners

value n/a

14 dealmakers

United States

Pharmaceuticals

Private EquityPrivateAcquisitionMajorityCross Border

target

Clario (drug Safety Solutions Unit)

bidder

Stanley Capital Partners

value n/a

19 dealmakers

United States

Biotechnology

PrivatePrivate EquityAcquisitionMajorityDomestic

target

Taconic Biosciences

bidder

Avista Capital Partners

value n/a

25 dealmakers

United States

Software

Private EquityMajorityPrivateAcquisitionDomestic

target

CALYX

bidder

Glo Healthcare

value n/a

10 dealmakers

Germany

Pharmaceuticals

PrivateMinorityAcquisitionCross BorderPrivate Equity

target

Proteros Biostructures

bidder

Inflexion Private Equity

value n/a

25 dealmakers

Canada

Pharmaceuticals

AcquisitionMajorityCross BorderPrivate EquityPrivate

target

Nuchem Sciences

bidder

Sygnature Discovery

value n/a

9 dealmakers

United Kingdom

Pharmaceuticals

AcquisitionMinorityPrivatePrivate EquityDomestic

target

Antibody Analytics

bidder

Northedge Capital

value n/a

8 dealmakers

United States

Digital Services

AcquisitionDomesticMajorityPrivatePrivate Equity

target

Specialty Networks

bidder

Cardinal Health

£945m

10 dealmakers

United States

Biotechnology

AcquisitionCross BorderMajorityPrivate

target

YECURIS

bidder

Merieux Equity Partners

value n/a

6 dealmakers

United States

Biotechnology

DomesticAcquisitionMajorityPrivate

target

INVICRO

bidder

CALYX

value n/a

42 dealmakers

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required